RSS-Feed abonnieren
DOI: 10.1055/s-0030-1270344
Decidual Hemostasis, Inflammation, and Angiogenesis in Pre-Eclampsia
Publikationsverlauf
Publikationsdatum:
02. März 2011 (online)
![](https://www.thieme-connect.de/media/sth/201102/lookinside/thumbnails/10.1055-s-0030-1270344-1.jpg)
ABSTRACT
Invasion of the decidua by extravillous trophoblasts (EVTs) is accompanied by thrombin generation from decidual cell (DC)-expressed tissue factor (TF). This TF protects against hemorrhage as EVTs breach capillaries and subsequently invade and remodel spiral arteries and arterioles. Pre-eclampsia (P-EC) is the world's leading cause of fetal and maternal morbidity and mortality. It is associated with decidual hemorrhage and maternal thrombophilias, which form excess thrombin from DCs, and with maternal infections and other inflammatory conditions that are associated with excess expression of the proinflammatory cytokines interleukin (IL)-1 β and tumor necrosis factor (TNF) α. In human first-trimester leukocyte-free DCs, (1) thrombin enhances expression of soluble fms-like tyrosine kinase-1 (sFlt-1), a potent inhibitor of angiogenesis; (2) thrombin, IL-1β and TNF-α increase monocyte-recruiting chemokine expression leading to a macrophage excess in the pre-eclamptic decidua. The pathogenesis of P-EC likely stems from shallow EVT invasion leading to impaired decidual vascular remodeling. The resulting reduced uteroplacental blood flow is associated with a hypoxic placenta, which appears to secrete excess sFlt-1 into the maternal plasma. A regulatory role for DCs in vascular remodeling is indicated because impaired decidual vascular remodeling could stem from an aberrant local antiangiogenic milieu elicited by excess sFlt-1 and/or macrophage-inhibited EVT decidual invasion.
KEYWORDS
Decidua - tissue factor - hemostasis - angiogenesis - pre-eclampsia
REFERENCES
- 1 Drake T A, Morrissey J H, Edgington T S. Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am J Pathol. 1989; 134 (5) 1087-1097
- 2 Mackman N. Role of tissue factor in hemostasis, thrombosis, and vascular development. Arterioscler Thromb Vasc Biol. 2004; 24 (6) 1015-1022
- 3 Tilley R, Mackman N. Tissue factor in hemostasis and thrombosis. Semin Thromb Hemost. 2006; 32 (1) 5-10
- 4 Levi M, van der Poll T. Two-way interactions between inflammation and coagulation. Trends Cardiovasc Med. 2005; 15 (7) 254-259
- 5 Levi M, ten Cate H, Bauer K A et al. Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees. J Clin Invest. 1994; 93 (1) 114-120
- 6 Erlich J, Parry G C, Fearns C et al. Tissue factor is required for uterine hemostasis and maintenance of the placental labyrinth during gestation. Proc Natl Acad Sci U S A. 1999; 96 (14) 8138-8143
- 7 Carmeliet P, Mackman N, Moons L et al. Role of tissue factor in embryonic blood vessel development. Nature. 1996; 383 (6595) 73-75
- 8 Brenner B. Haemostatic changes in pregnancy. Thromb Res. 2004; 114 (5–6) 409-414
- 9 Lockwood C J, Nemerson Y, Guller S et al. Progestational regulation of human endometrial stromal cell tissue factor expression during decidualization. J Clin Endocrinol Metab. 1993; 76 (1) 231-236
- 10 Lockwood C J, Krikun G, Papp C et al. The role of progestationally regulated stromal cell tissue factor and type-1 plasminogen activator inhibitor (PAI-1) in endometrial hemostasis and menstruation. Ann N Y Acad Sci. 1994; 734 57-79
- 11 Runic R, Schatz F, Krey L et al. Alterations in endometrial stromal cell tissue factor protein and messenger ribonucleic acid expression in patients experiencing abnormal uterine bleeding while using Norplant-2 contraception. J Clin Endocrinol Metab. 1997; 82 (6) 1983-1988
- 12 Moore K. Formation of the bilaminar embryo. In: Wonsiewicz M, ed. The Developing Human: Clinically Oriented Embryology. 4th ed. Philadelphia, PA: WB Saunders; 1988: 38-49
- 13 Pijnenborg R, Vercruysse L, Hanssens M. The uterine spiral arteries in human pregnancy: facts and controversies. Placenta. 2006; 27 (9–10) 939-958
- 14 Edmonds D K, Lindsay K S, Miller J F, Williamson E, Wood P J. Early embryonic mortality in women. Fertil Steril. 1982; 38 (4) 447-453
- 15 Miller J F, Williamson E, Glue J, Gordon Y B, Grudzinskas J G, Sykes A. Fetal loss after implantation. A prospective study. Lancet. 1980; 2 (8194) 554-556
- 16 Lockwood C J, Murk W, Kayisli U A et al. Progestin and thrombin regulate tissue factor expression in human term decidual cells. J Clin Endocrinol Metab. 2009; 94 (6) 2164-2170
- 17 Coughlin S R. Protease-activated receptors in hemostasis, thrombosis and vascular biology. J Thromb Haemost. 2005; 3 (8) 1800-1814
- 18 Marin V, Farnarier C, Grès S et al. The p38 mitogen-activated protein kinase pathway plays a critical role in thrombin-induced endothelial chemokine production and leukocyte recruitment. Blood. 2001; 98 (3) 667-673
- 19 Tsopanoglou N E, Maragoudakis M E. Role of thrombin in angiogenesis and tumor progression. Semin Thromb Hemost. 2004; 30 (1) 63-69
- 20 Lockwood C J, Krikun G, Aigner S, Schatz F. Effects of thrombin on steroid-modulated cultured endometrial stromal cell fibrinolytic potential. J Clin Endocrinol Metab. 1996; 81 (1) 107-112
- 21 Hirota Y, Osuga Y, Hirata T et al. Evidence for the presence of protease-activated receptor 2 and its possible implication in remodeling of human endometrium. J Clin Endocrinol Metab. 2005; 90 (3) 1662-1669
- 22 Zhou Y, Damsky C H, Fisher S J. Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome?. J Clin Invest. 1997; 99 (9) 2152-2164
- 23 Caniggia I, Mostachfi H, Winter J et al. Hypoxia-inducible factor-1 mediates the biological effects of oxygen on human trophoblast differentiation through TGFbeta(3). J Clin Invest. 2000; 105 (5) 577-587
- 24 Soleymanlou N, Jurisica I, Nevo O et al. Molecular evidence of placental hypoxia in preeclampsia. J Clin Endocrinol Metab. 2005; 90 (7) 4299-4308
- 25 Young B C, Levine R J, Karumanchi S A. Pathogenesis of preeclampsia. Annu Rev Pathol. 2010; 5 173-192
- 26 Redman C W, Sargent I L. Pre-eclampsia, the placenta and the maternal systemic inflammatory response—a review. Placenta. 2003; 24 (Suppl A) S21-S27
- 27 Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005; 365 (9461) 785-799
- 28 Dunn C L, Kelly R W, Critchley H O. Decidualization of the human endometrial stromal cell: an enigmatic transformation. Reprod Biomed Online. 2003; 7 (2) 151-161
- 29 Abrahams V M, Kim Y M, Straszewski S L, Romero R, Mor G. Macrophages and apoptotic cell clearance during pregnancy. Am J Reprod Immunol. 2004; 51 (4) 275-282
- 30 Lockwood C J, Matta P, Krikun G et al. Regulation of monocyte chemoattractant protein-1 expression by tumor necrosis factor-alpha and interleukin-1beta in first trimester human decidual cells: implications for preeclampsia. Am J Pathol. 2006; 168 (2) 445-452
- 31 Reister F, Frank H G, Kingdom J C et al. Macrophage-induced apoptosis limits endovascular trophoblast invasion in the uterine wall of preeclamptic women. Lab Invest. 2001; 81 (8) 1143-1152
- 32 Bauer S, Pollheimer J, Hartmann J, Husslein P, Aplin J D, Knöfler M. Tumor necrosis factor-alpha inhibits trophoblast migration through elevation of plasminogen activator inhibitor-1 in first-trimester villous explant cultures. J Clin Endocrinol Metab. 2004; 89 (2) 812-822
- 33 Salafia C M, López-Zeno J A, Sherer D M, Whittington S S, Minior V K, Vintzileos A M. Histologic evidence of old intrauterine bleeding is more frequent in prematurity. Am J Obstet Gynecol. 1995; 173 (4) 1065-1070
- 34 Nagy S, Bush M, Stone J, Lapinski R H, Gardó S. Clinical significance of subchorionic and retroplacental hematomas detected in the first trimester of pregnancy. Obstet Gynecol. 2003; 102 (1) 94-100
- 35 Aoyama K, Suzuki Y, Sato T et al. Cardiac failure caused by severe pre-eclampsia with placental abruption, and its treatment with anti-hypertensive drugs. J Obstet Gynaecol Res. 2003; 29 (5) 339-342
- 36 Rosen T, Kuczynski E, O'Neill L M, Funai E F, Lockwood C J. Plasma levels of thrombin-antithrombin complexes predict preterm premature rupture of the fetal membranes. J Matern Fetal Med. 2001; 10 (5) 297-300
- 37 Matta P, Lockwood C J, Schatz F et al. Thrombin regulates monocyte chemoattractant protein-1 expression in human first trimester and term decidual cells. Am J Obstet Gynecol. 2007; 196 (3) 268, e1-e8
- 38 Huang S J, Schatz F, Masch R et al. Regulation of chemokine production in response to pro-inflammatory cytokines in first trimester decidual cells. J Reprod Immunol. 2006; 72 (1-2) 60-73
- 39 Huang S J, Chen C P, Schatz F, Rahman M, Abrahams V M, Lockwood C J. Pre-eclampsia is associated with dendritic cell recruitment into the uterine decidua. J Pathol. 2008; 214 (3) 328-336
- 40 Zhou Y, McMaster M, Woo K et al. Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Pathol. 2002; 160 (4) 1405-1423
- 41 Park C W, Park J S, Shim S S, Jun J K, Yoon B H, Romero R. An elevated maternal plasma, but not amniotic fluid, soluble fms-like tyrosine kinase-1 (sFlt-1) at the time of mid-trimester genetic amniocentesis is a risk factor for preeclampsia. Am J Obstet Gynecol. 2005; 193 (3 Pt 2) 984-989
- 42 Lockwood C J, Toti P, Arcuri F et al. Thrombin regulates soluble fms-like tyrosine kinase-1 (sFlt-1) expression in first trimester decidua: implications for preeclampsia. Am J Pathol. 2007; 170 (4) 1398-1405
- 43 Levine R J, Lam C, Qian C CPEP Study Group et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med. 2006; 355 (10) 992-1005
- 44 Dubinsky V, Poehlmann T G, Suman P, Gentile T, Markert U R, Gutierrez G. Role of regulatory and angiogenic cytokines in invasion of trophoblastic cells. Am J Reprod Immunol. 2010; 63 (3) 193-199
- 45 Lockwood C J, Krikun G, Caze R, Rahman M, Buchwalder L F, Schatz F. Decidual cell-expressed tissue factor in human pregnancy and its involvement in hemostasis and preeclampsia-related angiogenesis. Ann N Y Acad Sci. 2008; 1127 67-72
Frederick SchatzPh.D.
Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine
333 Cedar Street, LSOG room 409, New Haven, CT 06510
eMail: frederick.schatz@yale.edu